StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$27.45−1.09 (-3.82%)

Close on Nov 17, 2026Market cap $1.33BP/E –Yield –

Nanobiotix total assets

Total assets on the balance sheet at the end of each period.

Nanobiotix's total assets was €128.33M at Jun 30, 2026. For fiscal 2025 it was €67.76M, up 0.5% from the year before. The highest annual figure on record is €134.03M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025€67.76M+0.5%
FY2024Dec 31, 2024€67.42M-28.2%
FY2023Dec 31, 2023€93.90M+57.1%
FY2022Dec 31, 2022€59.77M-41.3%
FY2021Dec 31, 2021€101.77M-24.1%
FY2020Dec 31, 2020€134.03M+138.5%
FY2019Dec 31, 2019€56.21M+9.0%
FY2018Dec 31, 2018€51.58M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026€128.33M+48.1%
Q4 FY2025Dec 31, 2025€67.76M-27.8%
Q2 FY2025Jun 30, 2025€45.17M+11.8%
Q4 FY2024Dec 31, 2024€67.42M+12.8%
Q2 FY2024Jun 30, 2024€86.68M+7.5%
Q4 FY2023Dec 31, 2023€93.90M-7.7%
Q2 FY2023Jun 30, 2023€40.41M-67.4%
Q4 FY2022Dec 31, 2022€59.77M-55.4%
Q2 FY2022Jun 30, 2022€80.62M+43.4%
Q4 FY2021Dec 31, 2021€101.77M+97.3%
Q2 FY2021Jun 30, 2021€123.92M–
Q4 FY2020Dec 31, 2020€134.03M–
Q4 FY2019Dec 31, 2019€56.21M–
Q4 FY2018Dec 31, 2018€51.58M–

More Nanobiotix figures

See a number that looks wrong?